{"id":"W4205228191","doi":"10.1016/j.annonc.2021.12.012","title":"Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody–drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Adverse effect; Pharmacokinetics; Carcinoembryonic antigen; Internal medicine; Population; Oncology; Antibody-drug conjugate; Antibody; Cancer; Pharmacology; Gastroenterology; Monoclonal antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000816141,0.0005849258,0.001100488,0.0003036197,0.0002056736,0.0005887889,0.0003687849,0.0005516746,0.001465735],"category_scores_gemma":[0.0008777471,0.0003451958,0.0007291589,0.0003143966,0.0004636702,0.0005467479,0.0001686082,0.001668604,0.0004446946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007083011,"about_ca_system_score_gemma":0.0004580987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005771682,"about_ca_topic_score_gemma":0.0006961776,"domain_scores_codex":[0.9996017,0.0001998289,0.00001938912,0.00006665903,0.00005091651,0.00006157286],"domain_scores_gemma":[0.9995021,0.0001060572,0.0001399928,0.00007176534,0.0000314196,0.0001486901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4734442,0.03692493,0.04235363,0.000484531,0.001935388,0.0004647299,0.0004906174,0.005811862,0.2011159,0.000367301,0.002262628,0.2343443],"study_design_scores_gemma":[0.05130437,0.7490395,0.1406177,0.00004117613,0.001606538,0.001115712,0.0002120648,0.007961421,0.0414305,0.0003337963,0.006258259,0.00007898421],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998329,0.0008236315,0.000160363,0.00005466046,0.0000148081,0.00005227475,0.0001378416,0.00002060636,0.0004069481],"genre_scores_gemma":[0.9984994,0.0003557508,0.000128326,0.00007447923,0.00002602119,0.00004166764,0.0002658904,0.000008790351,0.0005996214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001465735,"threshold_uncertainty_score":0.005139053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02869993499896342,"score_gpt":0.3813805163275267,"score_spread":0.3526805813285633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}